Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
MariMed Inc (MRMD)
OTHER OTC:MRMD
Holding MRMD?
Track your performance easily
Earnings Data
Report Date
Apr 02, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-$0.01Last Year’s EPS
$0Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 06, 2024
|% Change Since: -16.67%
|Next Earnings Date:Apr 02, 2025
Earnings Call Sentiment|Neutral
The earnings call presents a mixed sentiment with strong revenue growth driven by the wholesale business and strategic expansions into new markets. However, challenges such as declining retail revenue, gross margin, and adjusted EBITDA alongside higher-than-expected preopening costs due to delays suggest a balanced outlook.Company Guidance
During MariMed Inc.'s Q3 2024 earnings call, the company provided updated guidance for the year, highlighting revenue growth expectations of 6% to 8%, an increase from the previous 5% to 7%, while adjusted EBITDA is projected to decline by 18% to 20% compared to previous projections of flat to up 2%. The call detailed sequential improvements in adjusted EBITDA, attributed to reduced general and administrative costs, despite a year-over-year decline driven by lower gross margins and increased strategic growth expenditures. The company reported third-quarter revenue of $40.6 million, marking a 4.6% year-on-year increase and a marginal 0.4% sequential rise, driven by robust wholesale growth. Non-GAAP adjusted gross margin stood at 42.6%, down from last year's 44.5%, impacted by inflation and start-up costs in new markets. MariMed ended the quarter with $9.8 million in cash, and its year-to-date operational cash flow of $7.2 million represented a 54% increase from the previous year, underscoring effective cost management and operational improvements. Capital expenditures year-to-date were $10.9 million, down from $14.7 million the prior year, reflecting fewer asset build-outs.Sequential Revenue Growth
Reported year-over-year and sequential revenue growth with wholesale revenue growing 3% sequentially to a record $16.3 million, up 20% year-over-year.
Expansion of Brands
Expanded brands into new and existing markets with Betty's achieving the #7 ranked edible brand in Illinois and dominating Maryland with top-selling SKUs.
Operational and Strategic Growth
Brought 10 new revenue-generating operations online and began early preparations for a second adult-use dispensary in Ohio.
Strong Cash Flow from Operations
Generated $7.2 million in cash flow from operations year-to-date, a 54% increase from the previous year.
---
MRMD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
MRMD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 06, 2024 | $0.15 | $0.15 | 0.00% |
| Aug 07, 2024 | $0.17 | $0.18 | +5.88% |
| May 08, 2024 | $0.29 | $0.28 | -3.45% |
| Mar 06, 2024 | $0.24 | $0.24 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does MariMed Inc (MRMD) report earnings?
MariMed Inc (MRMD) is schdueled to report earning on Apr 02, 2025, TBA Not Confirmed.
What is MariMed Inc (MRMD) earnings time?
MariMed Inc (MRMD) earnings time is at Apr 02, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MRMD EPS forecast?
MRMD EPS forecast for the fiscal quarter 2024 (Q4) is -$0.01.
---